home / stock / viri / viri news

VIRI News and Press, Virios Therapeutics Inc. From 08/10/23

Stock Information
Company Name: Virios Therapeutics Inc.
Stock Symbol: VIRI
Market: NASDAQ
Website: virios.com
Menu
VIRI VIRI Quote VIRI Short VIRI News VIRI Articles VIRI Message Board
Get VIRI Alerts

News, Short Squeeze, Breakout and More Instantly...
VIRI - LGHL and EBIX among mid-day movers

2023-08-10 13:25:55 ET Gainers: WeWork ( WE ) +87% . Capri Holdings Limited ( CPRI ) +56% . Black Spade Acquisition ( BSAQ ) +58% . Edible Garden AG Incorporated ( EDBL ) +43% . Lion Group Holding Ltd. ( LGHL ) +37% . Precige...
VIRI - LifeMD, Precigen top healthcare gainers; Galera, Virios lead losers' pack

2023-08-10 10:27:32 ET Gainers: LifeMD ( LFMD ) +20% . Precigen ( PGEN ) +19% . Repare Therapeutics ( RPTX ) +16% . Cosmos Health ( COSM ) +13% . GoodRx Holdings ( GDRX ) +13% . Losers: Galera Therapeutics ( GRTX ) -...

VIRI - Virios Therapeutics, Inc. (VIRI) Q2 2023 Earnings Call Transcript

2023-08-10 10:05:09 ET Virios Therapeutics, Inc. (VIRI) Q2 2023 Earnings Conference Call August 10, 2023 08:30 AM ET Company Participants Angela Walsh - Senior Vice President, Finance & Treasurer Greg Duncan - Chief Executive Officer Mike Gendreau - Chief Med...

VIRI - Virios Therapeutics GAAP EPS of -$0.08 beats by $0.01

2023-08-10 07:08:09 ET Virios Therapeutics press release ( NASDAQ: VIRI ): Q2 GAAP EPS of -$0.08 beats by $0.01 . As of June 30, 2023, Virios Therapeutics’ cash totaled $4.6 million. The Company believes that the Company’s cash balance at June 30, 202...
VIRI - Virios Therapeutics Announces Second Quarter 2023 Financial Results and Provides Corporate Update

- Continued Progress in Expanding and Advancing Clinical Pipeline - - Conference Call Today at 8:30 a.m. ET - ATLANTA, Aug. 10, 2023 (GLOBE NEWSWIRE) -- Virios Therapeutics, Inc. (Nasdaq: VIRI) (the “Company”), a development-stage biotechnology company focused on adv...

VIRI - Virios Therapeutics Announces Plans to Advance Lead Candidate IMC-1 to Phase 3 Development as a New Treatment Option for Fibromyalgia

ATLANTA, Aug. 09, 2023 (GLOBE NEWSWIRE) -- Virios Therapeutics, Inc. (Nasdaq: VIRI) (the “Company”), a development-stage biotechnology company focused on advancing novel antiviral therapies to treat debilitating chronic diseases such as fibromyalgia (“FM”) and ...

VIRI - Virios Therapeutics to Report Second Quarter 2023 Financial Results on Thursday, August 10, 2023

ATLANTA, Aug. 03, 2023 (GLOBE NEWSWIRE) -- Virios Therapeutics, Inc. (Nasdaq: VIRI ) (the “Company”), a development-stage biotechnology company focused on advancing novel, combination antiviral therapies to treat debilitating chronic diseases, including fibromyalgia (&#x...
VIRI - RUN, SUNW and REKR are among pre market gainers

2023-07-18 08:13:35 ET Biophytis  ( BPTS ) +63% on agreement with SEQENS to produce Sarconeos active compound. The Singing Machine  ( MICS ) +32% . Karyopharm Therapeutics ( KPTI ) +21% granted Fast Track designation for selinexor for myelofibro...

VIRI - RMTI, QSI and BNED among mid-day movers

2023-07-17 13:40:37 ET Gainers: BridgeBio Pharma BBIO +78% . Acumen Pharmaceuticals ABOS +64% . GreenPower Motor Company GP +41% . Prestige Wealth PWM +39% . Quantum-Si incorporated ( QSI ) +35% . Lixte Biotechnology Holdings ( LIXT ) ...

VIRI - Virios Therapeutics Announces Positive Data Demonstrating Improvement in Multiple Long-COVID Symptoms Following Treatment with a Combination of Valacyclovir and Celecoxib in an Exploratory, Open-Label, Proof of Concept Study

ATLANTA, July 17, 2023 (GLOBE NEWSWIRE) -- Virios Therapeutics, Inc. (Nasdaq: VIRI) (the “Company”), a development-stage biotechnology company focused on advancing novel antiviral therapies to treat debilitating chronic diseases, including fibromyalgia (“FM”), ...
Previous 10 Next 10